miR-141-3p is a key negative regulator of the EGFR pathway in osteosarcoma
Author(s) -
Jiashi Wang,
Guangbin Wang,
Bin Li,
Chuang Qiu,
Ming He
Publication year - 2018
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s171304
Subject(s) - osteosarcoma , western blot , cell growth , microrna , cancer research , apoptosis , immunohistochemistry , transfection , biology , microbiology and biotechnology , cell culture , gene , immunology , biochemistry , genetics
Many studies have used miRNA to modulate osteosarcoma development by regulating protein expression, and these studies showed that the expression of EGFR is increased in osteosarcoma.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom